Top Markets
Coin of the day
Anhui Anke Biotechnology (Group) Co., Ltd. Anhui Anke Biotechnology (Group) Co., Ltd.

Anhui Anke Biotechnology (Group) Co., Ltd.

300009
Rank in Stocks #6268
Anhui Anke Biotechnology (Group) Co., Ltd. is engaged in the research,... Anhui Anke Biotechnology (Group) Co., Ltd. is engaged in the research, manufacturing, and global distribution of pharmaceutical goods, serving both domestic Chinese and international markets. Its flagship offerings include Ansomone, a brand of recombinant human growth hormone administered via injection, and the Anterferon line, which comprises recombinant human interferon alpha 2b in various forms such as lyophilized powder, liquid, and prefilled syringes for injection, alongside creams, eye drops, and suppositories. The company also supplies an array of diagnostic kits, including those for detecting anti-sperm antibodies, performing semen leukocyte peroxidase staining, single-use semen processing, sperm hypo-osmotic staining, assessing sperm viability, analyzing sperm morphology, determining sperm acrosin levels, identifying sperm DNA fragmentation, and for leptin and immunohistochemical analyses. Furthermore, their product portfolio extends to adhesive bandages, liquid oral medications, various topical formulations (including creams and ointments), active pharmaceutical ingredients (APIs) derived from peptides, cosmetic and anti-aging treatments, and synthetic pharmaceutical compounds available as powders, dripping pills, and both tablets and capsules. Moreover, Anke Biotechnology offers genetic testing solutions, encompassing kits for autosomal, sex chromosome, and combined autosomal and sex chromosome analyses, along with complete paternity testing packages. They also develop biological immunotherapy treatments for tumors and provide specialized DNA testing services. Established in 2000, the firm's headquarters are situated in Hefei, China.
Share Price
$1.28
Market Cap
$2.13B
Change (1 day)
0.34%
Change (1 year)
-18.11%
Country
CN
Trade Anhui Anke Biotechnology (Group) Co., Ltd. (300009)

Category

Stock split history for Anhui Anke Biotechnology (Group) Co., Ltd. (300009)
Anhui Anke Biotechnology (Group) Co., Ltd. stock (symbol: 300009) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 27, 2026.
One 300009 share bought prior to Aug 27, 2026 would equal to 0 300009 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH